Business / Finance

RSS

CardioNet first quarter revenue decreases 20.5% to $27.0 million

CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the first quarter-ended March 31, 2012.

9 May 2012

Tornier first quarter sales increase to $74.5 million

Tornier N.V., a global medical device company focused on providing surgical solutions to orthopaedic extremity specialists, today reported its financial results for the first quarter of 2012 and updated its fiscal 2012 financial outlook.

9 May 2012

Bacterin International announces third national GPO contract with Novation

Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, announces its third national GPO contract, a three-year agreement with Novation, a leading health care supply chain expert and contracting company.

8 May 2012

Bayer Yakuhin, Santen enter co-promotion agreement for EYLEA Injection in Japan

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer's Japanese subsidiary, Bayer Yakuhin, Ltd., and Santen Pharmaceutical Co., Ltd. entered into a co-promotion agreement for EYLEA aflibercept) Injection in Japan.

From Santen Pharmaceutical Co., Ltd. 8 May 2012

Mindray first quarter net revenues increase 21.1% to $219.0 million

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the first quarter ended March 31, 2012.

From Mindray 8 May 2012

Hillenbrand second quarter net income decreases 17% to $27M

Hillenbrand revenue for the second quarter of 2012 grew 13% to $260 million compared to the same quarter last year.

8 May 2012

Genesis Biopharma terminates previously announced proposed public offering

Genesis Biopharma, Inc., a biotechnology company developing targeted cancer immunotherapies, announced today that it is terminating its previously announced proposed public offering pursuant to a preliminary prospectus supplement and an effective shelf registration statement on file with the Securities and Exchange Commission due to market conditions.

8 May 2012

iCAD first quarter total revenue decreases 14% to $6.3 million

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today reported financial results for the first quarter ended March 31, 2012.

8 May 2012

Halozyme first quarter net loss increases to $15.1 million

Halozyme Therapeutics, Inc. today reported financial results for the quarter ended March 31, 2012.

8 May 2012

ProAssurance reports operating income of $48M for first quarter 2012

ProAssurance Corporation reports Operating Income of $48 million, or $1.56 per diluted share for the first quarter of 2012.

8 May 2012

Solazyme first quarter total revenue increases to $13.6 million

Solazyme, Inc., a renewable oil and bioproducts company, announced today financial results for the first quarter ended March 31, 2012 and recent key corporate highlights.

8 May 2012

Maxygen first quarter net loss increases to $2.6 million

Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter ended March 31, 2012.

8 May 2012

Salix first quarter total product revenue increases 62% to $171.1M

Salix Pharmaceuticals, Ltd. today announced financial and operating results for the first quarter ended March 31, 2012 and other business updates.

8 May 2012

Landauer second quarter revenue increases 21% to $39.1 million

Landauer, Inc., a recognized leader in personal and environmental radiation monitoring, outsourced medical physics services and high quality medical consumable accessories, today reported financial results for its fiscal 2012 second quarter ended March 31, 2012.

8 May 2012

Oncothyreon first quarter net income increases to $9.7 million

Oncothyreon Inc. today reported financial results for the first quarter ending March 31, 2012.

8 May 2012

Nautilus first quarter net sales increase 6.1% to $51.3 million

Nautilus, Inc. reported today its unaudited operating results for the first quarter ended March 31, 2012.

8 May 2012

Clinverse closes $3.8 million Series B round of funding

Clinverse, Inc., the global cloud-based ecommerce platform provider for clinical trials, announced today that it has closed a $3.8 million Series B round of funding led by Hatteras Venture Partners of Durham, NC. Vital Financial of Bethesda, MD, also participated in this funding round.

8 May 2012

Baxter declares quarterly dividend of $0.335 per common share

The Board of Directors of Baxter International Inc. today declared a quarterly dividend of $0.335 per Baxter common share.

From Baxter International Inc. 8 May 2012

Affymax first quarter total revenue increases to $63.2 million

Affymax, Inc. today reported financial results for the first quarter ended March 31, 2012. The net income for the first quarter of 2012 was $31.5 million (or $0.87 per share) compared to a net loss of $9.6 million (or $(0.36) per share) for the first quarter of 2011.

8 May 2012

Stereotaxis to raise $18.5M

Stereotaxis, Inc. today announced it has entered into definitive agreements with select institutional investors to raise total gross proceeds of approximately $18.5 million in two financing transactions.

7 May 2012